October 2011 Br J Cardiol 2011;18:217
Drs Ewan J McKay, Tina Tian, Nick Gerning, Chris Sawh, Pankaj Garg, John Purvis, Sinead Hughes and Mark Noble
When the dentist said: “Be still your beating heart!” Dear Sirs, We all often encounter a patient history and apparent presenting complaint that we can not precisely and cleverly explain. Our patient, Mr BW, a fit and active 53-year-old man, attended a routine appointment as an outpatient. He had done this many times previously as he was experiencing difficuties with heart rate control and troubling symptoms secondary to atrial fibrillation (AF). Coincidentally, he had also had amalgam dental fillings drilled some 18 months previously. Since then, his cardiac problems had escalated. There appeared no clear causality between the fillings a
February 2011 Br J Cardiol 2011;18:11-3
Highlights of the American Heart Association 2010 meeting held in November 2010, in Chicago, USA, included a breakthrough for the treatment of resistant hypertension, and another oral anticoagulant that could be used instead of warfarin in atrial fibrillation patients, without the need for monitoring. RAFT: CRT reduces deaths and hospitalisations in mild heart failure Adding cardiac-resynchronisation therapy (CRT) to implantable cardioverter defibrillator (ICD) and medication, led to a reduction in deaths and heart failure hospitalistions among patients with mild-to-moderate symptoms of heart failure in the RAFT (Resynchronisation-Defibrilla
May 2010 Br J Cardiol 2010;17:111-5
BJ Cardio Staff
ACCORD/INVEST: do not aim for normal blood pressure in diabetes patients with CAD The results of two trials comparing intensive versus more conventional blood pressure lowering in patients with diabetes at high cardiovascular risk have suggested that intensive treatment is not necessary and may be harmful in this population. In the ACCORD BP (Action to Control Cardiovascular Risk in Diabetes – Blood Pressure) trial, while intensive blood pressure treatment did reduce the risk of stroke, it failed to reduce the overall risk of cardiovascular events in patients and was associated with an increase in adverse events due to antihypertensive ther
March 2010 Br J Cardiol 2010;17:81-5
Kathryn E Griffith, Philip A Kalra
(more…)
September 2006 Br J Cardiol 2006;13:332-37
BJCardio editorial team
No content available
July 2006 Br J Cardiol 2006;13:233-7
Bryan Williams
No content available
September 2005 Br J Cardiol 2005;12:387-91
Mohamed Bakr, Derek G Waller
No content available
March 2005 Br J Cardiol 2005;12:156-60
Terry McCormack, Mark Davis
No content available
July 2004 Br J Cardiol 2004;11:292-9
Andrei C Sposito, Jose Augusto S Barreto-Filho
No content available
July 2003 Br J Cardiol 2003;10:310-4
Mike Mead
No content available
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits